IV-I suppressed fasting and OGTT-stimulated C-peptide ( 62 % and 40 % , respectively ) , and it significantly lowered fasting glucose ( 67.4 4.5 mg/dL during IV-I vs. 90.9 1.8 mg/dL off insulin ; P < 0.05 ) .